Skip to main content

Animations

MJFF Publications

3101 - 3110 of 8404 Results
Title
Year
  • Year
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • Summary Details
    OPEN
    Title: Improving domain definition and outcome instrument selection: Lessons learned for OMERACT from imaging
    Journal Name: Seminars in Arthritis and Rheumatism
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: publisher-specific-oa
    DOI - Digital Object Identifier: 10.1016/j.semarthrit.2021.08.004
    Citation Count: 22
  • Summary Details
    RESTRICTED
    Title: Neuropathological Findings in a Case of Parkinsonism and Developmental Delay Associated with a Monoallelic Variant in PLXNA1
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28756
    Best OA location URL:
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Rab GTPases in Parkinson's disease: a primer
    Journal Name: Essays in Biochemistry
    Publisher: Portland Press Ltd.
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1042/ebc20210016
    Citation Count: 16
  • Summary Details
    RESTRICTED
    Title: Aducanumab: look before leaping
    Journal Name: Nature Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1038/s41591-021-01477-5
    Best OA location URL:
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Experimental colitis promotes sustained, sex-dependent, T-cell-associated neuroinflammation and parkinsonian neuropathology
    Journal Name: Acta Neuropathologica Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40478-021-01240-4
    Citation Count: 47
  • Summary Details
    OPEN
    Title: Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(21)00214-3
    Citation Count: 382
  • Summary Details
    OPEN
    Title: “Real‐Life” Remote Dystonia Assessment: Feasibility, Accuracy, and Practice Implications
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mdc3.13330
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Apathy: An underestimated feature in GBA and LRRK2 non-manifesting mutation carriers
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.08.008
    Citation Count: 10
  • Summary Details
    RESTRICTED
    Title: Multitarget Transcranial Electrical Stimulation for Freezing of Gait: A Randomized Controlled Trial
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28759
    Best OA location URL:
    Citation Count: 25
  • Summary Details
    OPEN
    Title: Polyglutamine‐Expanded Ataxin‐3: A Target Engagement Marker for Spinocerebellar Ataxia Type 3 in Peripheral Blood
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/mds.28749
    Citation Count: 28
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.